Cargando…
Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response.
Plasma sIl-2R and sCD8 levels of 12 patients with renal cell carcinoma were determined before and during subcutaneous rIl-2 therapy. Patients with a complete/partial remission showed a significantly stronger initial increase of sCD8 compared to patients with stable disease or tumour progression.
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1993
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968458/ https://www.ncbi.nlm.nih.gov/pubmed/8494709 |
| _version_ | 1782134744426741760 |
|---|---|
| author | Martens, A. Janssen, R. A. Sleijfer, D. T. Heijn, A. A. Mulder, N. H. The, T. H. de Leij, L. |
| author_facet | Martens, A. Janssen, R. A. Sleijfer, D. T. Heijn, A. A. Mulder, N. H. The, T. H. de Leij, L. |
| author_sort | Martens, A. |
| collection | PubMed |
| description | Plasma sIl-2R and sCD8 levels of 12 patients with renal cell carcinoma were determined before and during subcutaneous rIl-2 therapy. Patients with a complete/partial remission showed a significantly stronger initial increase of sCD8 compared to patients with stable disease or tumour progression. |
| format | Text |
| id | pubmed-1968458 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1993 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-19684582009-09-10 Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response. Martens, A. Janssen, R. A. Sleijfer, D. T. Heijn, A. A. Mulder, N. H. The, T. H. de Leij, L. Br J Cancer Research Article Plasma sIl-2R and sCD8 levels of 12 patients with renal cell carcinoma were determined before and during subcutaneous rIl-2 therapy. Patients with a complete/partial remission showed a significantly stronger initial increase of sCD8 compared to patients with stable disease or tumour progression. Nature Publishing Group 1993-05 /pmc/articles/PMC1968458/ /pubmed/8494709 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Article Martens, A. Janssen, R. A. Sleijfer, D. T. Heijn, A. A. Mulder, N. H. The, T. H. de Leij, L. Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response. |
| title | Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response. |
| title_full | Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response. |
| title_fullStr | Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response. |
| title_full_unstemmed | Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response. |
| title_short | Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response. |
| title_sort | early scd8 plasma levels during subcutaneous ril-2 therapy in patients with renal cell carcinoma correlate with response. |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968458/ https://www.ncbi.nlm.nih.gov/pubmed/8494709 |
| work_keys_str_mv | AT martensa earlyscd8plasmalevelsduringsubcutaneousril2therapyinpatientswithrenalcellcarcinomacorrelatewithresponse AT janssenra earlyscd8plasmalevelsduringsubcutaneousril2therapyinpatientswithrenalcellcarcinomacorrelatewithresponse AT sleijferdt earlyscd8plasmalevelsduringsubcutaneousril2therapyinpatientswithrenalcellcarcinomacorrelatewithresponse AT heijnaa earlyscd8plasmalevelsduringsubcutaneousril2therapyinpatientswithrenalcellcarcinomacorrelatewithresponse AT muldernh earlyscd8plasmalevelsduringsubcutaneousril2therapyinpatientswithrenalcellcarcinomacorrelatewithresponse AT theth earlyscd8plasmalevelsduringsubcutaneousril2therapyinpatientswithrenalcellcarcinomacorrelatewithresponse AT deleijl earlyscd8plasmalevelsduringsubcutaneousril2therapyinpatientswithrenalcellcarcinomacorrelatewithresponse |